Skip to content
  • Home
  • Catalog
  • About/Leadership
  • Press
  • Contact
  • —
  • Sign in

Twitter
Instagram
TikTok
Linkedin
Youtube

Your cart

  • Home
  • Catalog
  • About/Leadership
  • Press
  • Contact
FUNanc1al
0

Insider Purchases: Inside the Buy

Tag: MYNZ

Illustration showing advanced cancer diagnostics and DNA science balanced against financial risk, representing Mainz Biomed’s promising technology and high-risk biotech investment profile.

January 20, 2026

Insider Buys Shares of Mainz Biomed: Promising Science, Precarious Finances

Mainz Biomed’s cancer-screening science is compelling — and an insider just bought big. But with heavy losses, dilution risk, and a going-concern warning, MYNZ is a biotech moonshot best approached with extreme caution.

Read entire article

Tags: 10% owner buying, Biotech Stocks, buy or sell MYNZ, Colorectal Cancer, Early Cancer Detection, featured-insiders, funanc1al edge, funanc1al humor, funanc1al investing, FUNstock Index, Going Concern, High Risk High Reward, hub-insiders, hub-overseas, Insider Buying, Mainz Biomed, Microcap Biotech, MYNZ, Pancreatic Cancer, risks buying mynz, Speculative Stocks, why buy mynz

Quick links

Search
Privacy Policy
Refund Policy
Shipping Policy
Terms of Service

Contact us

@funanc1al
customer_service@funanc1al.com

About us

FUNanc!al distills the fun in finance and the finance in fun, makes news personal, and helps all reach happiness.

Follow us

Twitter
Instagram
TikTok
Linkedin
Youtube

© Copyright 2026 FUNanc1al
Powered by Shopify